TBRG.NASDAQTrubridge, INC

8-K: TruBridge Reports Mixed Q1 Results, Revises Full-Year Revenue Outlook

Sentiment:

Quarterly Report


TruBridge announced its first quarter 2024 financial results, showing increased bookings but a decrease in total revenue and adjusted EBITDA, leading to a revised full-year revenue outlook.

Delay expectedThe company revised its full-year revenue guidance due to the variability in time to convert larger deals, indicating a delay in revenue recognition.
Worse than expectedThe company reported a GAAP loss per share compared to a profit in the same quarter last year.Non-GAAP earnings per share and adjusted EBITDA decreased year-over-year.The full-year revenue guidance was revised downwards.

Summary

  • TruBridge reported first quarter 2024 results with bookings increasing to $23.6 million from $19.8 million in the same quarter last year.
  • Total revenue decreased to $83.2 million from $86.2 million year-over-year.
  • Revenue Cycle Management (RCM) revenue grew to $53.0 million, representing 63.7% of total revenue, compared to $48.6 million in the prior year.
  • The company reported a GAAP loss per diluted share of $(0.17) compared to earnings of $0.21 in the first quarter of 2023.
  • Non-GAAP earnings per diluted share were $0.19, down from $0.58 year-over-year.
  • Adjusted EBITDA decreased to $9.5 million from $14.6 million in the same period last year.
  • TruBridge has revised its full-year revenue guidance to $330 million to $340 million, down from the previous range of $340 million to $350 million.
  • The company maintained its full-year adjusted EBITDA outlook of $45 million to $50 million.
  • For the second quarter of 2024, TruBridge expects total revenue between $81 million and $83 million and adjusted EBITDA between $8.0 million and $10.0 million.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to decreased revenue, earnings, and adjusted EBITDA, along with a downward revision of the full-year revenue guidance. While bookings increased, the overall financial performance and outlook are concerning.

Positives

  • Bookings increased year-over-year, indicating strong sales momentum.
  • RCM revenue experienced growth, demonstrating strength in this key segment.
  • The company is focused on improving financial operations, forecasting, and cost savings.
  • TruBridge has a strong position in terms of profitability due to expense management.
  • The company has a growing pipeline of larger deals, particularly in the RCM business.

Negatives

  • Total revenue decreased year-over-year, indicating a slowdown in overall business.
  • GAAP earnings per diluted share resulted in a loss, compared to a profit in the same quarter last year.
  • Non-GAAP earnings per diluted share decreased significantly year-over-year.
  • Adjusted EBITDA decreased compared to the same period last year.
  • The full-year revenue guidance was revised downwards, reflecting challenges in converting larger deals to revenue.

Risks

  • The company faces risks related to market saturation and hospital consolidations.
  • Unfavorable economic conditions could lead to decreased spending on IT and services.
  • Legislative and regulatory uncertainty in the healthcare industry poses a risk.
  • The company is exposed to liability for failure to comply with regulatory requirements.
  • Pandemics and other public health crises could cause economic disruptions.
  • Competition from companies with greater resources is a significant risk.
  • Potential delays in developing markets for RCM services could impact growth.
  • The company's reliance on an international workforce exposes it to business disruptions.
  • The use of artificial intelligence could expose the company to liability.
  • Breaches of security and viruses in systems could result in customer claims and harm to reputation.
  • The company is exposed to liability in the event it provides inaccurate claims data to payors.
  • The company has substantial indebtedness and is subject to restrictive terms in its credit agreement.
  • Fluctuations in quarterly financial performance due to the timing of customer installations is a risk.
  • The company is vulnerable to significant damage from natural disasters.

Future Outlook

TruBridge expects total revenue of $81 million to $83 million and adjusted EBITDA of $8.0 million to $10.0 million for the second quarter of 2024. The full-year revenue guidance has been revised to $330 million to $340 million, while the full-year adjusted EBITDA outlook remains at $45 million to $50 million.

Management Comments

  • Chris Fowler, CEO, stated that the company continued to make significant progress on transformation efforts.
  • Fowler noted that the refinement of financial operations gives enhanced capabilities in forecasting and capital allocation.
  • Fowler mentioned that the company was pleased with the continued momentum in bookings.
  • Fowler stated that the company feels it's prudent to slightly revise the full-year revenue range due to the variability in time to convert larger deals.
  • Fowler concluded that the company remains confident it can continue to deliver for customers and shareholders.

Industry Context

TruBridge operates in the healthcare solutions market, which is experiencing significant demand for technology-driven solutions. The company's focus on RCM and EHR solutions aligns with industry trends towards improving financial and clinical outcomes for healthcare providers. The revised revenue guidance may reflect broader challenges in the healthcare IT sector, such as longer sales cycles and implementation timelines.

Comparison to Industry Standards

  • TruBridge's performance is mixed when compared to industry peers. While the increase in bookings is a positive sign, the decrease in revenue and adjusted EBITDA is concerning.
  • Companies like Cerner (now Oracle Health) and Epic Systems, which are major players in the EHR market, often report higher revenue and profitability due to their larger scale and established customer base.
  • In the RCM space, companies like R1 RCM and Optum are known for their strong revenue growth and operational efficiency. TruBridge's RCM growth is positive but needs to be sustained to compete effectively.
  • The revision of the full-year revenue guidance suggests that TruBridge is facing challenges in converting bookings into revenue, which is a common issue in the healthcare IT sector due to complex sales cycles and implementation processes.
  • The company's adjusted EBITDA margin of 11.4% is lower than some of its peers, indicating potential areas for improvement in cost management and operational efficiency.

Stakeholder Impact

  • Shareholders may be concerned about the decreased revenue, earnings, and revised revenue guidance.
  • Customers may be impacted by the company's focus on larger deals, potentially leading to longer implementation timelines.
  • Employees may be affected by the company's ongoing transformation efforts and cost-saving initiatives.
  • Creditors may be concerned about the company's substantial indebtedness and ability to service its debt.

Next Steps

  • TruBridge will hold a live webcast to discuss first quarter 2024 results on May 10, 2024.
  • A 30-day online replay of the webcast will be available.

Key Dates

DateDescription
March 31, 2024End of the first fiscal quarter for which financial results are reported.
May 10, 2024Date of the press release and 8-K filing announcing the first quarter 2024 results and the date of the conference call.

Keywords

Healthcare Solutions, Revenue Cycle Management, RCM, EHR, Bookings, Adjusted EBITDA, Financial Results, Earnings, Revenue, Guidance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.